PrestoCost Comms

P2X receptors (P2XRs) have an established role in many diseases. Evidence generated mainly by leading Europe-based laboratories, shows that P2XRs may be an ideal pharmacological target. The transfer of this wealth of knowledge from research laboratories to the patients’ bed has been slow, and clinical trials carried out have been unsatisfactory. This was due to a noticeable lack of coordinated effort by basic research, clinical & industry-based investigators. The PRESTO Action aims to accelerate the transition of P2XRs knowledge to clinical applications. The videos are based upon work from COST Action CA21130, Supported by COST (European Cooperation in Science and Technology). COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.